Dogwood Therapeutics (DWTX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.25, -1.57% vs the prior close of $1.27.
- Volume 100.40K shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DWTX dips 1.6% to $1.25, a 52-week low, 8 down days in a row. Closed at $1.25, -1.57% vs the prior close of $1.27. Day range $1.18–$1.29, opened at $1.28.
DWTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DWTX dips 1.6% to $1.25, a 52-week low, 8 down days in a row
- Closed at $1.25, -1.57% vs the prior close of $1.27. Day range $1.18–$1.29, opened at $1.28.
- Volume was 100.40K shares, 1.4x its 50-day average of 69.31K.
- Price is -32.9% vs its 50-day average ($1.86) and -40.6% vs its 200-day average ($2.11).
- 52-week range $1.18–$7.04; today's close sits at 1% of that range, 82.3% below the 52-week high.
- That makes 8 straight losses.
Oct 14, 2026 — DWTX dips 2.3% to $1.27, a 52-week low, 7 down days in a row
- Closed at $1.27, -2.31% vs the prior close of $1.30. Day range $1.24–$1.34, opened at $1.31.
- Volume was 83.10K shares, 1.2x its 50-day average of 69.10K.
- Price is -32.2% vs its 50-day average ($1.87) and -40.1% vs its 200-day average ($2.12).
- 52-week range $1.24–$7.04; today's close sits at 1% of that range, 82.0% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — DWTX slides 5.1% to $1.30, a 52-week low, 6 down days in a row
- Closed at $1.30, -5.11% vs the prior close of $1.37. Day range $1.29–$1.38, opened at $1.37.
- Volume was 109.20K shares, 1.6x its 50-day average of 68.60K.
- Price is -31.0% vs its 50-day average ($1.88) and -39.1% vs its 200-day average ($2.13).
- 52-week range $1.28–$7.04; today's close sits at 0% of that range, 81.5% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — DWTX dips 2.1% to $1.37, 5 down days in a row
- Closed at $1.37, -2.14% vs the prior close of $1.40. Day range $1.37–$1.46, opened at $1.42.
- Volume was 43.90K shares, 0.6x its 50-day average of 68.73K.
- Price is -27.6% vs its 50-day average ($1.89) and -36.3% vs its 200-day average ($2.15).
- 52-week range $1.28–$7.04; today's close sits at 2% of that range, 80.6% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — DWTX dips 0.7% to $1.40, 4 down days in a row
- Closed at $1.40, -0.71% vs the prior close of $1.41. Day range $1.40–$1.54, opened at $1.45.
- Volume was 66.30K shares, 1.0x its 50-day average of 67.57K.
- Price is -26.2% vs its 50-day average ($1.90) and -35.3% vs its 200-day average ($2.16).
- 52-week range $1.28–$7.04; today's close sits at 2% of that range, 80.1% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — DWTX dips 1.4% to $1.41, 3 down days in a row
- Closed at $1.41, -1.40% vs the prior close of $1.43. Day range $1.41–$1.48, opened at $1.48.
- Volume was 62.50K shares, 0.9x its 50-day average of 67.66K.
- Price is -25.9% vs its 50-day average ($1.90) and -35.3% vs its 200-day average ($2.18).
- 52-week range $1.28–$7.04; today's close sits at 2% of that range, 80.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — DWTX slides 5.9% to $1.43
- Closed at $1.43, -5.92% vs the prior close of $1.52. Day range $1.43–$1.51, opened at $1.50.
- Volume was 50.30K shares, 0.7x its 50-day average of 67.39K.
- Price is -24.9% vs its 50-day average ($1.90) and -35.1% vs its 200-day average ($2.20).
- 52-week range $1.28–$7.20; today's close sits at 3% of that range, 80.1% below the 52-week high.
Oct 6, 2026 — DWTX ends flat (+0.0%) to $1.52 on 1.9x normal volume
- Closed at $1.52, +0.00% vs the prior close of $1.52. Day range $1.46–$1.64, opened at $1.57.
- Volume was 125.60K shares, 1.9x its 50-day average of 64.96K — unusually heavy trading.
- Price is -20.3% vs its 50-day average ($1.91) and -31.8% vs its 200-day average ($2.23).
- 52-week range $1.28–$7.20; today's close sits at 4% of that range, 78.9% below the 52-week high.
Oct 5, 2026 — DWTX jumps 4.1% to $1.52, 3 up days in a row
- Closed at $1.52, +4.11% vs the prior close of $1.46. Day range $1.45–$1.72, opened at $1.50.
- Volume was 99.80K shares, 1.6x its 50-day average of 63.34K.
- Price is -20.3% vs its 50-day average ($1.91) and -32.5% vs its 200-day average ($2.25).
- 52-week range $1.28–$7.20; today's close sits at 4% of that range, 78.9% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — DWTX rises 2.1% to $1.46
- Closed at $1.46, +2.10% vs the prior close of $1.43. Day range $1.43–$1.56, opened at $1.45.
- Volume was 71.10K shares, 1.1x its 50-day average of 62.74K.
- Price is -23.4% vs its 50-day average ($1.91) and -35.9% vs its 200-day average ($2.28).
- 52-week range $1.28–$7.30; today's close sits at 3% of that range, 80.0% below the 52-week high.
DWTX latest news & SEC filings
Every SEC filing by or about DWTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$11.53M (prior year -$3.81M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.34 (prior year -$1.99) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade DWTX
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 18, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.75% (largest 5.9%).
- Liquidity: about 71.40K shares (≈$89.25K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.25 vs a range of $1.18–$7.04 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 8-K Aug 13, 2026; 8-K Jun 17, 2026.
- Share count: 33.99M shares outstanding (Aug 13, 2026), +1678.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
DWTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.28 | 1.29 | 1.18 | 1.25 | 100.40K |
| Oct 14, 2026 | 1.31 | 1.34 | 1.24 | 1.27 | 83.10K |
| Oct 13, 2026 | 1.37 | 1.38 | 1.29 | 1.30 | 109.20K |
| Oct 12, 2026 | 1.42 | 1.46 | 1.37 | 1.37 | 43.90K |
| Oct 9, 2026 | 1.45 | 1.54 | 1.40 | 1.40 | 66.30K |
| Oct 8, 2026 | 1.48 | 1.48 | 1.41 | 1.41 | 62.50K |
| Oct 7, 2026 | 1.50 | 1.51 | 1.43 | 1.43 | 50.30K |
| Oct 6, 2026 | 1.57 | 1.64 | 1.46 | 1.52 | 125.60K |
| Oct 5, 2026 | 1.50 | 1.72 | 1.45 | 1.52 | 99.80K |
| Oct 2, 2026 | 1.45 | 1.56 | 1.43 | 1.46 | 71.10K |
| Oct 1, 2026 | 1.36 | 1.45 | 1.35 | 1.43 | 26.50K |
| Sep 30, 2026 | 1.35 | 1.39 | 1.32 | 1.35 | 34.30K |
| Sep 29, 2026 | 1.38 | 1.45 | 1.30 | 1.35 | 79.60K |
| Sep 28, 2026 | 1.40 | 1.46 | 1.35 | 1.36 | 82.10K |
| Sep 25, 2026 | 1.44 | 1.52 | 1.34 | 1.36 | 46.40K |
| Sep 24, 2026 | 1.51 | 1.55 | 1.42 | 1.43 | 17.20K |
| Sep 23, 2026 | 1.51 | 1.57 | 1.45 | 1.51 | 23.60K |
| Sep 22, 2026 | 1.63 | 1.76 | 1.48 | 1.51 | 128.20K |
| Sep 21, 2026 | 1.67 | 1.73 | 1.58 | 1.60 | 61.70K |
| Sep 18, 2026 | 1.74 | 1.83 | 1.60 | 1.69 | 116.20K |
About Dogwood Therapeutics
Dogwood Therapeutics (DWTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ALPHARETTA, GA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1818844.
DWTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Life Sciences Intl (Holdings) Inc Ck | See Remarks | Nov 25, 2025 |
| Inc. Conjoint | See Remarks | Nov 25, 2025 |
| La Rosa Abel De | Director | Jun 17, 2026 |
| Gregory Scott Duncan | CHIEF EXECUTIVE OFFICER | Mar 6, 2026 |
| David R Keefer | Director | Jun 17, 2026 |
| Ltd Sealbond | See Remarks | Nov 25, 2025 |
| John C Thomas | Director | Jun 17, 2026 |
| Richard James Whitley | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gregory Scott Duncan | CHIEF EXECUTIVE OFFICER | Mar 6, 2026 |
| Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Mar 6, 2026 |
| Ralph Grosswald | SVP OF OPERATIONS | Mar 6, 2026 |
| Angela Walsh | Chief Financial Officer | Mar 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
DWTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-34.26M | -7.13 | $-15.62M |
| Dec 31, 2024 | — | $-12.35M | -12.52 | $-8.79M |
| Dec 31, 2023 | — | $-5.30M | -7.05 | $-4.87M |
| Dec 31, 2022 | — | $-12.25M | -1.11 | $-11.47M |
| Dec 31, 2021 | — | $-15.96M | -1.92 | $-15.69M |
Latest balance sheet: total assets $80.50M, total liabilities $12.13M, cash $9.61M (as of Jun 30, 2026).
DWTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.98 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.98 |
| Mar 18, 2026 | 8-K Item 2.02 (results) | $2.97 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $5.20 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $4.80 |
| May 8, 2025 | 8-K Item 2.02 (results) | $4.56 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $5.01 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $4.45 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DWTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.